Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 440

1.

Capsid engineering overcomes barriers toward Adeno-associated viral (AAV) vector-mediated transduction of endothelial cells.

Zhang L, Rossi A, Lange L, Meumann N, Koitzsch U, Christie K, Nesbit A, Moore T, Hacker U, Morgan MA, Hoffmann D, Zengel JR, Carette JE, Schambach A, Salvetti A, Odenthal M, Büning H.

Hum Gene Ther. 2019 Aug 13. doi: 10.1089/hum.2019.027. [Epub ahead of print]

PMID:
31407607
2.

TDCIPP exposure affects Artemia franciscana growth and osmoregulation.

Morgan MA, Griffith CM, Volz DC, Larive CK.

Sci Total Environ. 2019 Jul 19;694:133486. doi: 10.1016/j.scitotenv.2019.07.292. [Epub ahead of print]

PMID:
31401516
3.

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer.

Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, Maybaum J, Zalupski MM, Lawrence TS.

J Clin Oncol. 2019 Aug 9:JCO1900730. doi: 10.1200/JCO.19.00730. [Epub ahead of print]

PMID:
31398082
4.

The "balloon on a string" appearance of the renal collecting system and ureter.

Morgan MA, El Jack AK.

Abdom Radiol (NY). 2019 Jul 25. doi: 10.1007/s00261-019-02152-7. [Epub ahead of print] Review. No abstract available.

PMID:
31346743
5.

Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment.

Buckingham L, Koenig A, Ko EM, Brensinger CM, Latif N, Hummel C, Zhang X, Morgan MA, Burger RA, Giuntoli Ii RL.

Int J Gynecol Cancer. 2019 Jul 12. pii: ijgc-2019-000566. doi: 10.1136/ijgc-2019-000566. [Epub ahead of print]

PMID:
31302627
6.

CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism.

Piunti A, Smith ER, Morgan MAJ, Ugarenko M, Khaltyan N, Helmin KA, Ryan CA, Murray DC, Rickels RA, Yilmaz BD, Rendleman EJ, Savas JN, Singer BD, Bulun SE, Shilatifard A.

Sci Adv. 2019 Jul 3;5(7):eaax2887. doi: 10.1126/sciadv.aax2887. eCollection 2019 Jul.

7.

The utility of retrograde pyelography to follow up incompletely opacified ureters on CT urography.

Paspulati A, Gupta A, Hill PA, Morgan MA.

Abdom Radiol (NY). 2019 Jul 3. doi: 10.1007/s00261-019-02121-0. [Epub ahead of print]

PMID:
31270562
8.

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors.

Nasioudis D, Ko EM, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Latif NA.

Gynecol Oncol Rep. 2019 Apr 17;28:145-148. doi: 10.1016/j.gore.2019.04.004. eCollection 2019 May.

9.

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.

Moore KN, Gunderson CC, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger RA, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE.

Gynecol Oncol. 2019 Aug;154(2):294-301. doi: 10.1016/j.ygyno.2019.04.001. Epub 2019 Jun 4.

PMID:
31174889
10.

Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.

Nasioudis D, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Ko EM, Latif NA.

Gynecol Oncol. 2019 Aug;154(2):302-307. doi: 10.1016/j.ygyno.2019.05.009. Epub 2019 May 31.

PMID:
31155308
11.

Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.

Zhang Q, Green MD, Lang X, Lazarus J, Parsels JD, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei YL, Lawrence TS, Zou W, Morgan MA.

Cancer Res. 2019 Aug 1;79(15):3940-3951. doi: 10.1158/0008-5472.CAN-19-0761. Epub 2019 May 17.

PMID:
31101760
12.

Evaluating sub-lethal stress from Roundup® exposure in Artemia franciscana using 1H NMR and GC-MS.

Morgan MA, Griffith CM, Dinges MM, Lyon YA, Julian RR, Larive CK.

Aquat Toxicol. 2019 Jul;212:77-87. doi: 10.1016/j.aquatox.2019.04.023. Epub 2019 May 1.

PMID:
31077969
13.

Reply to letter to the editor: "clinical evaluation of ureteral pseudodiverticulosis".

Morgan MA, Zafar HM, Papanicolaou N, Ramchandani P.

Abdom Radiol (NY). 2019 Jul;44(7):2677. doi: 10.1007/s00261-019-02040-0. No abstract available.

PMID:
31030243
14.

Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?

Nasioudis D, Ko EM, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Latif NA.

Gynecol Oncol Rep. 2019 Mar 13;28:86-90. doi: 10.1016/j.gore.2019.03.008. eCollection 2019 May.

15.

Pulmonary Function Testing and Cardiopulmonary Exercise Testing: An Overview.

Krol K, Morgan MA, Khurana S.

Med Clin North Am. 2019 May;103(3):565-576. doi: 10.1016/j.mcna.2018.12.014. Review.

PMID:
30955522
16.

The Sonographic Spectrum of Pelvic Endometriosis: Pearls, Pitfalls, and Mimics.

Jones LP, Morgan MA, Chauhan A.

Ultrasound Q. 2019 Mar 27. doi: 10.1097/RUQ.0000000000000436. [Epub ahead of print]

PMID:
30921101
17.

Discrepancies in diagnostic records of military service members with self-reported PTSD: Healthcare use and longitudinal symptom outcomes.

Morgan MA, Kelber MS, O'Gallagher K, Liu X, Evatt DP, Belsher BE.

Gen Hosp Psychiatry. 2019 May - Jun;58:33-38. doi: 10.1016/j.genhosppsych.2019.02.006. Epub 2019 Feb 26.

PMID:
30849678
18.

Renal Imaging: Core Curriculum 2019.

Fried JG, Morgan MA.

Am J Kidney Dis. 2019 Apr;73(4):552-565. doi: 10.1053/j.ajkd.2018.12.029. Epub 2019 Feb 15. Review.

PMID:
30777633
19.

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.

Krasner CN, Castro C, Penson RT, Roche M, Matulonis UA, Morgan MA, Drescher C, Armstrong DK, Wolfe JK, Lee H, Supko JG, Seiden M, Birrer MJ, Dizon DS.

Gynecol Oncol. 2019 May;153(2):223-229. doi: 10.1016/j.ygyno.2019.02.004. Epub 2019 Feb 12.

PMID:
30765148
20.

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

Kloess S, Oberschmidt O, Dahlke J, Vu XK, Neudoerfl C, Kloos A, Gardlowski T, Matthies N, Heuser M, Meyer J, Sauer M, Falk C, Koehl U, Schambach A, Morgan MA.

Hum Gene Ther. 2019 Apr;30(4):381-401. doi: 10.1089/hum.2018.247. Epub 2019 Mar 18.

PMID:
30734584
21.

The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.

Zhang Q, Mady ASA, Ma Y, Ryan C, Lawrence TS, Nikolovska-Coleska Z, Sun Y, Morgan MA.

Nucleic Acids Res. 2019 May 7;47(8):4039-4053. doi: 10.1093/nar/gkz058.

22.

Identifying research gaps in substance use disorder: A systematic methodology and prioritized list.

Kelber MS, Morgan MA, Beech EH, Workman DE, Evatt DP, Belsher BE, Garvey Wilson AL, Otto J, Campbell MS.

Am J Drug Alcohol Abuse. 2019;45(4):355-364. doi: 10.1080/00952990.2018.1558229. Epub 2019 Jan 22.

PMID:
30668154
23.

Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.

Morgan MA, Canman CE.

Cancer Res. 2018 Dec 15;78(24):6713-6716. doi: 10.1158/0008-5472.CAN-18-2439. Epub 2018 Nov 29. Review.

24.

Engineering CAR-T Cells for Improved Function Against Solid Tumors.

Morgan MA, Schambach A.

Front Immunol. 2018 Oct 29;9:2493. doi: 10.3389/fimmu.2018.02493. eCollection 2018. Review.

25.

TET2 coactivates gene expression through demethylation of enhancers.

Wang L, Ozark PA, Smith ER, Zhao Z, Marshall SA, Rendleman EJ, Piunti A, Ryan C, Whelan AL, Helmin KA, Morgan MA, Zou L, Singer BD, Shilatifard A.

Sci Adv. 2018 Nov 7;4(11):eaau6986. doi: 10.1126/sciadv.aau6986. eCollection 2018 Nov.

26.

A Guide to Midrotation Feedback.

Morgan MA, Jones LP.

J Am Coll Radiol. 2019 Feb;16(2):219-220. doi: 10.1016/j.jacr.2018.08.004. Epub 2018 Oct 30. No abstract available.

PMID:
30389331
27.

Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells.

Philipp F, Selich A, Rothe M, Hoffmann D, Rittinghausen S, Morgan MA, Klatt D, Glage S, Lienenklaus S, Neuhaus V, Sewald K, Braun A, Schambach A.

Stem Cell Reports. 2018 Nov 13;11(5):1051-1060. doi: 10.1016/j.stemcr.2018.09.010. Epub 2018 Oct 18.

28.

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers.

Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, Hu X, Zhang Y, Wang Y, Jiang J, Li C, Zhong X, Montone KT, Guan G, Tanyi JL, Fan Y, Xu X, Morgan MA, Long M, Zhang Y, Zhang R, Sood AK, Rebbeck TR, Dang CV, Zhang L.

Cancer Cell. 2018 Oct 8;34(4):549-560.e9. doi: 10.1016/j.ccell.2018.08.019.

PMID:
30300578
29.

Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors.

Morgan MA, Schambach A.

Hum Gene Ther. 2018 Oct;29(10):1083-1097. doi: 10.1089/hum.2017.251. Epub 2018 Aug 29. Review.

PMID:
30156435
30.

Pathology Consultation for the Gynecologic Oncologist: What the Surgeon Wants to Know.

Cory L, Morgan MA.

Arch Pathol Lab Med. 2018 Dec;142(12):1503-1508. doi: 10.5858/arpa.2018-0122-RA. Epub 2018 Aug 22. Review.

PMID:
30133316
31.

Ureteral pseudodiverticulosis and urothelial cell carcinoma: rethinking the association.

Morgan MA, Chua WY, Zafar HM, Papanicolaou N, Ramchandani P.

Abdom Radiol (NY). 2019 Jan;44(1):234-238. doi: 10.1007/s00261-018-1726-6.

PMID:
30078084
32.

Metabolic Profiling of Chloroacetanilide Herbicides in Earthworm Coelomic Fluid Using 1H NMR and GC-MS.

Griffith CM, Morgan MA, Dinges MM, Mathon C, Larive CK.

J Proteome Res. 2018 Aug 3;17(8):2611-2622. doi: 10.1021/acs.jproteome.8b00081. Epub 2018 Jul 16.

PMID:
29939029
33.

The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.

Parsels LA, Parsels JD, Tanska DM, Maybaum J, Lawrence TS, Morgan MA.

Cell Cycle. 2018;17(9):1076-1086. doi: 10.1080/15384101.2018.1475827. Epub 2018 Jul 18.

34.

Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma.

Morgan MA, Shilatifard A.

Cancer Cell. 2018 Jun 11;33(6):951-953. doi: 10.1016/j.ccell.2018.05.011.

35.

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.

Wang L, Zhao Z, Ozark PA, Fantini D, Marshall SA, Rendleman EJ, Cozzolino KA, Louis N, He X, Morgan MA, Takahashi YH, Collings CK, Smith ER, Ntziachristos P, Savas JN, Zou L, Hashizume R, Meeks JJ, Shilatifard A.

Nat Med. 2018 Jun;24(6):758-769. doi: 10.1038/s41591-018-0034-6. Epub 2018 May 21.

36.

Multiplexed precision genome editing with trackable genomic barcodes in yeast.

Roy KR, Smith JD, Vonesch SC, Lin G, Tu CS, Lederer AR, Chu A, Suresh S, Nguyen M, Horecka J, Tripathi A, Burnett WT, Morgan MA, Schulz J, Orsley KM, Wei W, Aiyar RS, Davis RW, Bankaitis VA, Haber JE, Salit ML, St Onge RP, Steinmetz LM.

Nat Biotechnol. 2018 Jul;36(6):512-520. doi: 10.1038/nbt.4137. Epub 2018 May 7.

37.

Voiding cystourethrography after prostatectomy: spectrum of appearances.

Morgan MA, Papanicolaou N.

Abdom Radiol (NY). 2018 Nov;43(11):3060-3067. doi: 10.1007/s00261-018-1564-6. Review.

PMID:
29556701
38.

Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.

Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, Bushman FD, June CH, Facciabene A.

JCI Insight. 2018 Feb 22;3(4). pii: 94952. doi: 10.1172/jci.insight.94952. eCollection 2018 Feb 22.

39.

An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells.

Cao K, Collings CK, Morgan MA, Marshall SA, Rendleman EJ, Ozark PA, Smith ER, Shilatifard A.

Sci Adv. 2018 Jan 31;4(1):eaap8747. doi: 10.1126/sciadv.aap8747. eCollection 2018 Jan.

40.

Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency.

Shapiro BB MD, MPH, Hedrick R, Vanle BC, Becker CA, Nguyen C, Underhill DM, Morgan MA, Kopple JD, Danovitch I, IsHak WW.

BMJ Case Rep. 2018 Jan 26;2018. pii: bcr-2017-221435. doi: 10.1136/bcr-2017-221435.

PMID:
29374632
41.

Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01329-17. doi: 10.1128/JCM.01329-17. Print 2018 Apr.

42.

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy.

Cuneo KC, Morgan MA, Griffith KA, Hawkins PG, Greenson JK, Ben-Josef E, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):490-497. doi: 10.1016/j.ijrobp.2017.10.030. Epub 2017 Oct 28.

43.

Long-lived unipotent Blimp1-positive luminal stem cells drive mammary gland organogenesis throughout adult life.

Elias S, Morgan MA, Bikoff EK, Robertson EJ.

Nat Commun. 2017 Nov 20;8(1):1714. doi: 10.1038/s41467-017-01971-w.

44.

PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.

Parsels LA, Karnak D, Parsels JD, Zhang Q, Vélez-Padilla J, Reichert ZR, Wahl DR, Maybaum J, O'Connor MJ, Lawrence TS, Morgan MA.

Mol Cancer Res. 2018 Feb;16(2):222-232. doi: 10.1158/1541-7786.MCR-17-0455. Epub 2017 Nov 13.

45.

The Future of Radiobiology.

Kirsch DG, Diehn M, Kesarwala AH, Maity A, Morgan MA, Schwarz JK, Bristow R, Demaria S, Eke I, Griffin RJ, Haas-Kogan D, Higgins GS, Kimmelman AC, Kimple RJ, Lombaert IM, Ma L, Marples B, Pajonk F, Park CC, Schaue D, Tran PT, Willers H, Wouters BG, Bernhard EJ.

J Natl Cancer Inst. 2018 Apr 1;110(4):329-340. doi: 10.1093/jnci/djx231.

46.

Uncoupling the Oncogenic Engine.

Schambach A, Schott JW, Morgan MA.

Cancer Res. 2017 Nov 15;77(22):6060-6064. doi: 10.1158/0008-5472.CAN-17-2362. Epub 2017 Nov 2. Review.

47.

A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation.

Morgan MAJ, Rickels RA, Collings CK, He X, Cao K, Herz HM, Cozzolino KA, Abshiru NA, Marshall SA, Rendleman EJ, Sze CC, Piunti A, Kelleher NL, Savas JN, Shilatifard A.

Genes Dev. 2017 Oct 1;31(19):2003-2014. doi: 10.1101/gad.305201.117.

48.

Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.

Roberson PL, Smith LB, Morgan MA, Schipper MJ, Wilderman SJ, Avram AM, Kaminski MS, Dewaraja YK.

Cancer Biother Radiopharm. 2017 Nov;32(9):309-319. doi: 10.1089/cbr.2017.2182. Epub 2017 Oct 30.

49.

Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.

Rickels R, Herz HM, Sze CC, Cao K, Morgan MA, Collings CK, Gause M, Takahashi YH, Wang L, Rendleman EJ, Marshall SA, Krueger A, Bartom ET, Piunti A, Smith ER, Abshiru NA, Kelleher NL, Dorsett D, Shilatifard A.

Nat Genet. 2017 Nov;49(11):1647-1653. doi: 10.1038/ng.3965. Epub 2017 Oct 2.

50.

Histone H3K4 methylation-dependent and -independent functions of Set1A/COMPASS in embryonic stem cell self-renewal and differentiation.

Sze CC, Cao K, Collings CK, Marshall SA, Rendleman EJ, Ozark PA, Chen FX, Morgan MA, Wang L, Shilatifard A.

Genes Dev. 2017 Sep 1;31(17):1732-1737. doi: 10.1101/gad.303768.117. Epub 2017 Sep 22.

Supplemental Content

Loading ...
Support Center